Evidence map›Paper›PMID 34561984›Full record

ReviewCurrent neuropharmacology2022

Effects of Natural Products on Neuromuscular Junction.

Esra Küpeli Akkol, Gökçe Şeker Karatoprak, Elif Carpar, Yaseen Hussain, Haroon Khan, Michael Aschner

Open access · greenAbstract readReview
In one paragraph

Review in Current neuropharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Esra Küpeli AkkolDepartment of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330, Ankara, Turkey.
Gökçe Şeker KaratoprakDepartment of Pharmacognosy, Faculty of Pharmacy, Erciyes University, 38039, Kayseri, Turkey.
Elif CarparDepartment of Psychiatry, Private French La Paix Hospital, 34360, Istanbul, Turkey.
Yaseen HussainCollege of Pharmaceutical Sciences, Soochow University, Suzhou, Jiangsu, China.
Haroon KhanDepartment of Pharmacy, Abdul Wali Khan University Mardan, 23200, Mardan, Pakistan.
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine Forchheimer 209 1300 Morris Park Avenue, Bronx, NY 10461.
Abdul Wali Khan University Mardan · PKAlbert Einstein College of Medicine · USErciyes University · TRGazi University · TRSoochow University · CN

Funding

Mechanisms of Methylmercury Induced Neuron ToxicityR01ES007331 · NIEHS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Michael Aschner, Aaron B Bowman · 1996 to 2026
$10.6M
National Institute of Environmental Health Science (NIEHS) R01ES07331, R01ES10563
6 · The paper itself

Abstract

Neuromuscular junction (NMJ) disorders result from damage, malfunction or absence of one or more key proteins involved in neuromuscular transmission, comprising a wide range of disorders. The most common pathology is antibody-mediated or downregulation of ion channels or receptors, resulting in Lambert-Eaton myasthenic syndrome, myasthenia gravis, and acquired neuromyotonia (Isaac's syndrome), and rarely congenital myasthenic syndromes caused by mutations in NMJ proteins. A wide range of symptomatic treatments, immunomodulating therapies, or immunosuppressive drugs have been used to treat NMJ diseases. Future research must be directed at a better understanding of the pathogenesis of these diseases, and developing novel disease-specific treatments. Numerous secondary metabolites, especially alkaloids isolated from plants, have been used to treat NMJ diseases in traditional and clinical practices. An ethnopharmacological approach has provided leads for identifying new treatments for NMJ diseases. In this review, we performed a literature survey in Pubmed, Science Direct, and Google Scholar to gather information on drug discovery from plant sources for NMJ disease treatments. To date, most research has focused on the effects of herbal remedies on cholinesterase inhibitory and antioxidant activities. This review provides leads for identifying potential new drugs from plant sources for the treatment of NMJ diseases.

Indexed as

Biological ProductsLambert-Eaton Myasthenic SyndromeMyasthenia GravisHumansNeuromuscular JunctionSynaptic TransmissionBiological ProductsAcetylcholinesteraselambert-eaton myasthenic syndromemyasthenia gravisnatural productneuromuscular junctionNMJ diseases

Identifiers

PMID34561984
PMCPMC9608237
OpenAlexW3199513944

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.